ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 160 filers reported holding ZIOPHARM ONCOLOGY INC in Q4 2020. The put-call ratio across all filers is 1.51 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $26,163 | -85.9% | 198,500 | -45.4% | 0.00% | – |
| Q2 2023 | $185,280 | -5.7% | 363,294 | +16.5% | 0.00% | – |
| Q1 2023 | $196,458 | -69.3% | 311,838 | -68.4% | 0.00% | – |
| Q4 2022 | $640,745 | +49.7% | 987,129 | +296.3% | 0.00% | – |
| Q3 2022 | $428,000 | +94.5% | 249,063 | +40.6% | 0.00% | – |
| Q2 2022 | $220,000 | -23.3% | 177,108 | -59.7% | 0.00% | – |
| Q1 2022 | $287,000 | -64.2% | 439,349 | -40.3% | 0.00% | – |
| Q4 2021 | $802,000 | -27.6% | 735,701 | +20.9% | 0.00% | – |
| Q3 2021 | $1,108,000 | -37.6% | 608,712 | -9.5% | 0.00% | – |
| Q2 2021 | $1,777,000 | +26.5% | 672,873 | +72.4% | 0.00% | – |
| Q1 2021 | $1,405,000 | +21.9% | 390,400 | -14.7% | 0.00% | – |
| Q4 2020 | $1,153,000 | -31.7% | 457,573 | -31.6% | 0.00% | – |
| Q3 2020 | $1,687,000 | +16.4% | 669,080 | +51.5% | 0.00% | – |
| Q2 2020 | $1,449,000 | +18.0% | 441,649 | -11.9% | 0.00% | – |
| Q1 2020 | $1,228,000 | -56.9% | 501,484 | -17.0% | 0.00% | -100.0% |
| Q4 2019 | $2,851,000 | +108.3% | 603,872 | +88.7% | 0.00% | – |
| Q3 2019 | $1,369,000 | -37.5% | 319,985 | -14.9% | 0.00% | – |
| Q2 2019 | $2,191,000 | +166.2% | 375,855 | +75.8% | 0.00% | – |
| Q1 2019 | $823,000 | -20.8% | 213,800 | -61.5% | 0.00% | – |
| Q4 2018 | $1,039,000 | -49.3% | 555,648 | -13.3% | 0.00% | -100.0% |
| Q3 2018 | $2,050,000 | +15.7% | 640,895 | +9.3% | 0.00% | – |
| Q2 2018 | $1,772,000 | +1.9% | 586,472 | +32.2% | 0.00% | -100.0% |
| Q1 2018 | $1,739,000 | -15.1% | 443,530 | -10.3% | 0.00% | 0.0% |
| Q4 2017 | $2,048,000 | -3.8% | 494,595 | +42.6% | 0.00% | -50.0% |
| Q3 2017 | $2,130,000 | -9.5% | 346,801 | -8.3% | 0.00% | 0.0% |
| Q2 2017 | $2,353,000 | +14.6% | 378,349 | +16.8% | 0.00% | 0.0% |
| Q1 2017 | $2,053,000 | +44.6% | 323,948 | +22.0% | 0.00% | +100.0% |
| Q4 2016 | $1,420,000 | +5.5% | 265,430 | +11.0% | 0.00% | -50.0% |
| Q3 2016 | $1,346,000 | -65.8% | 239,164 | -66.7% | 0.00% | -50.0% |
| Q2 2016 | $3,939,000 | +328.6% | 717,559 | +548.8% | 0.00% | +300.0% |
| Q4 2015 | $919,000 | -74.7% | 110,600 | -72.5% | 0.00% | -66.7% |
| Q3 2015 | $3,626,000 | +212.0% | 402,456 | +315.5% | 0.00% | +200.0% |
| Q2 2015 | $1,162,000 | +160.0% | 96,852 | +133.5% | 0.00% | – |
| Q1 2015 | $447,000 | +59.1% | 41,471 | -25.1% | 0.00% | – |
| Q4 2014 | $281,000 | +16.1% | 55,367 | -39.6% | 0.00% | – |
| Q3 2014 | $242,000 | -2.4% | 91,715 | +49.2% | 0.00% | – |
| Q2 2014 | $248,000 | +92.2% | 61,460 | +117.4% | 0.00% | – |
| Q1 2014 | $129,000 | -29.5% | 28,271 | -33.1% | 0.00% | – |
| Q4 2013 | $183,000 | +490.3% | 42,234 | +443.6% | 0.00% | – |
| Q3 2013 | $31,000 | -82.6% | 7,770 | -90.8% | 0.00% | – |
| Q2 2013 | $178,000 | – | 84,809 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 14,013,093 | $9,142,000 | 0.78% |
| MSD Partners, L.P. | 15,151,516 | $9,885,000 | 0.54% |
| MSD Partners, L.P. | 7,575,758 | $4,942,000 | 0.27% |
| CHIRON CAPITAL MANAGEMENT, LLC | 144,960 | $95,000 | 0.06% |
| MAGNOLIA CAPITAL ADVISORS LLC | 185,456 | $121,000 | 0.05% |
| Allred Capital Management, LLC | 128,000 | $83,000 | 0.04% |
| Virtus ETF Advisers LLC | 131,413 | $86,000 | 0.04% |
| GSA CAPITAL PARTNERS LLP | 232,438 | $152,000 | 0.02% |
| ACT WEALTH MANAGEMENT, LLC | 37,071 | $24,000 | 0.01% |
| Pathway Financial Advisors LLC | 30,000 | $20,000 | 0.01% |